.png)
Precision Targeting in Rare Disease: Why Lab Data is the "Early Warning System" Pharma Needs
We are living in an era of unprecedented rare disease advocacy. Medical parents and patient groups...
The Data Quality Illusion: Why Aggregated EHR Feeds Often Fail
In the life sciences industry, "lab data" is often treated as a commodity. The assumption is that a...
Tracking the Shift: Real-World Adoption of Emerging IHC Markers in Early 2026
Moving beyond the "hype" to seeing actual testing adoption on the ground.